HK1121762A1 - Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders - Google Patents
Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disordersInfo
- Publication number
- HK1121762A1 HK1121762A1 HK09101838.5A HK09101838A HK1121762A1 HK 1121762 A1 HK1121762 A1 HK 1121762A1 HK 09101838 A HK09101838 A HK 09101838A HK 1121762 A1 HK1121762 A1 HK 1121762A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- intermediates
- gastrointestinal
- treatment
- nervous system
- central nervous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71314905P | 2005-08-31 | 2005-08-31 | |
US74776206P | 2006-05-19 | 2006-05-19 | |
PCT/US2006/034322 WO2007028073A2 (en) | 2005-08-31 | 2006-08-31 | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1121762A1 true HK1121762A1 (en) | 2009-04-30 |
Family
ID=37708472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09101838.5A HK1121762A1 (en) | 2005-08-31 | 2009-02-26 | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
Country Status (15)
Country | Link |
---|---|
US (3) | US7326787B2 (de) |
EP (1) | EP1919909B1 (de) |
JP (1) | JP5308818B2 (de) |
KR (1) | KR101351454B1 (de) |
CN (1) | CN102863374A (de) |
AU (1) | AU2006284601B2 (de) |
BR (1) | BRPI0615691A8 (de) |
CA (1) | CA2620379C (de) |
DK (1) | DK1919909T3 (de) |
ES (1) | ES2436100T3 (de) |
HK (1) | HK1121762A1 (de) |
IL (1) | IL189202A (de) |
NO (1) | NO340832B1 (de) |
RU (1) | RU2418798C2 (de) |
WO (1) | WO2007028073A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8138204B2 (en) * | 2004-01-07 | 2012-03-20 | Aryx Therapeutics, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
US8524736B2 (en) | 2004-01-07 | 2013-09-03 | Armetheon, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
AU2006284601B2 (en) * | 2005-08-31 | 2012-12-20 | Renexxion, Llc | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
WO2007149929A1 (en) * | 2006-06-23 | 2007-12-27 | Aryx Therapeutics, Inc. | Piperidine derivatives for the treatment of gastrointestinal and cns disorders |
IT1396373B1 (it) * | 2009-10-29 | 2012-11-19 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina. |
US10376145B2 (en) | 2015-02-24 | 2019-08-13 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
US10864367B2 (en) | 2015-02-24 | 2020-12-15 | Elira, Inc. | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
CN115227969A (zh) | 2015-02-24 | 2022-10-25 | 伊莱拉股份有限公司 | 使用电极皮肤贴实现食欲调节或改善饮食依从性的方法 |
US10335302B2 (en) | 2015-02-24 | 2019-07-02 | Elira, Inc. | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
US10765863B2 (en) | 2015-02-24 | 2020-09-08 | Elira, Inc. | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
US9956393B2 (en) | 2015-02-24 | 2018-05-01 | Elira, Inc. | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
US20220062621A1 (en) | 2015-02-24 | 2022-03-03 | Elira, Inc. | Electrical Stimulation-Based Weight Management System |
US10570127B1 (en) | 2018-11-05 | 2020-02-25 | Renexxion, Llc | Material and methods for the treatment of gastro-intestinal disorders |
WO2020096911A1 (en) | 2018-11-05 | 2020-05-14 | Renexxion, Llc | Methods of producing naronapride trihydrate |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) * | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
GB1425706A (en) | 1972-06-30 | 1976-02-18 | Wyeth John & Brother Ltd | Piperidine derivatives |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
CA1183847A (en) | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US5137896A (en) * | 1981-10-01 | 1992-08-11 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US5057525A (en) * | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
US4962115A (en) * | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US4870074A (en) * | 1986-04-30 | 1989-09-26 | Dainippon Pharmaceutical Co., Ltd. | Substituted benzamide derivatives, for enhancing gastrointestinal motility |
US4875439A (en) * | 1987-01-09 | 1989-10-24 | Brunswick Corporation | Marine propulsion system with fuel line cooler |
US4975439A (en) * | 1987-09-25 | 1990-12-04 | Janssen Pharmaceutical N.V. | Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
US5041454A (en) * | 1987-09-25 | 1991-08-20 | Janssen Pharmaceutica N.V. | Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
CA1317940C (en) | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
GB8902118D0 (en) * | 1989-02-01 | 1989-03-22 | Beecham Group Plc | Chemical process |
TW213460B (de) | 1991-02-15 | 1993-09-21 | Hokuriku Pharmaceutical | |
US5395832A (en) * | 1991-02-15 | 1995-03-07 | Hokuriku Seiyaku Co., Ltd. | Benzamide derivatives |
TW221996B (de) * | 1991-11-14 | 1994-04-01 | Glaxo Group Ltd | |
IT1260485B (it) * | 1992-05-29 | 1996-04-09 | Procedimento e dispositivo per il trattamento dell'obesita' di un paziente | |
CA2139636A1 (en) * | 1992-07-07 | 1994-01-20 | Nancy M. Gray | Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
CA2139638A1 (en) * | 1992-07-07 | 1994-01-20 | Nancy M. Gray | Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
WO1994010174A1 (en) * | 1992-11-05 | 1994-05-11 | Smithkline Beecham Plc | Piperidine derivatives as 5-ht4 receptor antagonists |
US5472866A (en) * | 1992-12-24 | 1995-12-05 | Synaptic Pharmaceutical Corporation | DNA encoding 5-HT4A serotonin receptors |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
US5739151A (en) * | 1996-07-19 | 1998-04-14 | Sepracor Inc. | Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
US6147093A (en) * | 1996-07-19 | 2000-11-14 | Sepracor Inc. | Methods for treating gastroesophageal reflux disease |
DK1000029T3 (da) | 1997-07-11 | 2004-02-23 | Janssen Pharmaceutica Nv | Norcisaprid nyttig med hensyn til 5-HT3- og 5-HT4- medierede lidelser |
JPH11292846A (ja) | 1998-02-10 | 1999-10-26 | Hokuriku Seiyaku Co Ltd | ベンズアミド誘導体及びそれを含有する医薬 |
AR022338A1 (es) * | 1999-02-04 | 2002-09-04 | Hokuriku Pharmaceutical | Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal. |
DE19933926A1 (de) | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Pharma | Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
US20040092511A1 (en) * | 1999-12-10 | 2004-05-13 | Billstein Stephan Anthony | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
AU2001275326C1 (en) | 2000-06-07 | 2006-09-21 | Aryx Therapeutics | Treatment of gastroesophageal reflux disease using piperidine derivatives |
MXPA03000145A (es) | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
PT1704146E (pt) * | 2004-01-07 | 2010-06-30 | Aryx Therapeutics Inc | Compostos estereoisoméricos e processos para o tratamento de distúrbios gastrointestinais e do sistema nervoso central |
AU2006284601B2 (en) * | 2005-08-31 | 2012-12-20 | Renexxion, Llc | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
-
2006
- 2006-08-31 AU AU2006284601A patent/AU2006284601B2/en active Active
- 2006-08-31 CA CA2620379A patent/CA2620379C/en active Active
- 2006-08-31 WO PCT/US2006/034322 patent/WO2007028073A2/en active Application Filing
- 2006-08-31 EP EP06802848.9A patent/EP1919909B1/de active Active
- 2006-08-31 KR KR1020087007843A patent/KR101351454B1/ko active IP Right Grant
- 2006-08-31 ES ES06802848T patent/ES2436100T3/es active Active
- 2006-08-31 CN CN2012102986251A patent/CN102863374A/zh active Pending
- 2006-08-31 RU RU2008112215/04A patent/RU2418798C2/ru active
- 2006-08-31 DK DK06802848.9T patent/DK1919909T3/da active
- 2006-08-31 JP JP2008529331A patent/JP5308818B2/ja active Active
- 2006-08-31 US US11/469,264 patent/US7326787B2/en active Active
- 2006-08-31 BR BRPI0615691A patent/BRPI0615691A8/pt not_active Application Discontinuation
-
2007
- 2007-12-05 US US11/950,914 patent/US20080076927A1/en not_active Abandoned
-
2008
- 2008-02-03 IL IL189202A patent/IL189202A/en active IP Right Grant
- 2008-03-28 NO NO20081562A patent/NO340832B1/no unknown
- 2008-04-25 US US12/109,500 patent/US7629466B2/en active Active
-
2009
- 2009-02-26 HK HK09101838.5A patent/HK1121762A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2418798C2 (ru) | 2011-05-20 |
US7629466B2 (en) | 2009-12-08 |
EP1919909B1 (de) | 2013-08-21 |
WO2007028073A3 (en) | 2007-05-24 |
NO340832B1 (no) | 2017-06-26 |
US20090137810A1 (en) | 2009-05-28 |
DK1919909T3 (da) | 2013-12-02 |
KR101351454B1 (ko) | 2014-01-14 |
AU2006284601B2 (en) | 2012-12-20 |
RU2008112215A (ru) | 2009-10-10 |
CA2620379C (en) | 2015-02-24 |
BRPI0615691A2 (pt) | 2011-05-24 |
JP2009507033A (ja) | 2009-02-19 |
AU2006284601A1 (en) | 2007-03-08 |
IL189202A0 (en) | 2008-06-05 |
BRPI0615691A8 (pt) | 2017-08-15 |
EP1919909A2 (de) | 2008-05-14 |
ES2436100T3 (es) | 2013-12-27 |
JP5308818B2 (ja) | 2013-10-09 |
US20070078265A1 (en) | 2007-04-05 |
KR20080041294A (ko) | 2008-05-09 |
US20080076927A1 (en) | 2008-03-27 |
US7326787B2 (en) | 2008-02-05 |
CA2620379A1 (en) | 2007-03-08 |
NO20081562L (no) | 2008-03-28 |
CN102863374A (zh) | 2013-01-09 |
IL189202A (en) | 2013-07-31 |
WO2007028073A2 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL189202A0 (en) | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders | |
HUS1900005I1 (hu) | Javított nanotestek (TM) aggregáció közvetítette rendellenességek kezelésére | |
IL178648A0 (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
IL179508A0 (en) | 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders | |
IL185016A0 (en) | Compounds for the treatment of proliferative disorders | |
IL175055A0 (en) | Combinations useful for the treatment of neuronal disorders | |
PL1890684T3 (pl) | Leczenie zaburzeń snu i czuwania | |
IL176581A0 (en) | Immunomodulatory compounds for the treatment of central nervous system disorders | |
EP1853539A4 (de) | Honokiol-derivate zur behandlung proliferativer erkrankungen | |
ZA200803440B (en) | Compounds for the treatment of metabolic disorders | |
HK1157575A1 (en) | Treating neurological disorders | |
EP2268140A4 (de) | Neue verbindungen, die vorteilhaft für die behandlung von erkrankungen und störungen des zentralnervensystems sind | |
ZA200801667B (en) | Novel pharmaceutical combinations for the treatment of respiratory disorders | |
SI2418201T1 (sl) | Polimorfne oblike (2s)-(4e)-n-metil-5(3-(5-izopropksipiridin)-il)-4-pen-ten-2-amin p-hidroksibenzoata za zdravljenje motenj osrednjega ĺ˝iväśnega sistema | |
IL187248A0 (en) | Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders | |
PL1841433T3 (pl) | Kompozycja do leczenia zaburzeń ośrodkowego układu nerwowego | |
EP1901770A4 (de) | Verfahren zur behandlung von wachstumsstörungen | |
ZA200805108B (en) | Treatment of neurodegenerative disorders | |
ZA200802270B (en) | Treatment of neurodegenerative disorders | |
PL1982178T3 (pl) | Sposoby leczenia zaburzeń afektywnych | |
ZA200801144B (en) | Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders | |
GB0604772D0 (en) | Use of substituted amine compounds for the treatment of food related disorders | |
GB0507552D0 (en) | Methods and compounds for the treatment of cognitive dysfunction | |
GB0512757D0 (en) | Treatment of respiratory disorders | |
GB0410966D0 (en) | Treatment of neural disorders |